Active substance
Results for the substance vamorolone
1 result
About this active substance
Vamorolone is an investigational drug primarily used for the treatment of Duchenne muscular dystrophy (DMD), a rare genetic disorder affecting skeletal and cardiac muscles. It is a dissociative corticosteroid that retains the anti-inflammatory effects of traditional corticosteroids but with fewer side effects, such as hypothalamic-pituitary-adrenal axis suppression and bone density loss.
Vamorolone works by modulating the expression of genes involved in inflammation and stabilizing cell membranes, helping to reduce inflammation and protect muscles affected by DMD. The medication is administered orally, and the dosage is adjusted based on the patient's age and weight.
Reported side effects are generally less severe than those associated with traditional corticosteroids and include nausea, headaches, and weight gain. Clinical trials are ongoing to fully evaluate the efficacy and safety of this drug.
Vamorolone represents a promising option for patients with DMD, offering a safer alternative to traditional corticosteroids and improving their quality of life.
Vamorolone works by modulating the expression of genes involved in inflammation and stabilizing cell membranes, helping to reduce inflammation and protect muscles affected by DMD. The medication is administered orally, and the dosage is adjusted based on the patient's age and weight.
Reported side effects are generally less severe than those associated with traditional corticosteroids and include nausea, headaches, and weight gain. Clinical trials are ongoing to fully evaluate the efficacy and safety of this drug.
Vamorolone represents a promising option for patients with DMD, offering a safer alternative to traditional corticosteroids and improving their quality of life.